Dr Lal PathLabs Financial Statements
Quarterly
Yearly
| Particulars | Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 |
|---|---|---|---|---|---|
| Revenue | 430.97 | 606.60 | 498.40 | 496.90 | 485.51 |
| Expenses | 329.29 | 436.80 | 377.40 | 418.40 | 402.09 |
| EBITDA | 101.68 | 169.80 | 121.00 | 78.50 | 83.42 |
| EBIT | 81.38 | 150.60 | 100.50 | 47.80 | 45.71 |
| Profit Before Tax | 110.81 | 179.30 | 130.60 | 81.50 | 83.58 |
| Net Profit | 83.42 | 131.20 | 95.00 | 57.30 | 61.33 |
| Financial Ratios | |||||
| Operating Profit Margin | 23.59% | 27.99% | 24.28% | 15.80% | 17.18% |
| Net Profit Margin | 19.36% | 21.63% | 19.06% | 11.53% | 12.63% |
| Earning Per Share (Diluted) | 10.09 | 15.84 | 11.45 | 6.90 | 7.41 |
| Dividends Per Share | 8.00 | NA | 6.00 | NA | 6.00 |
